Boston Scientific Co
BSX
Real-time BATS EXCHANGE - 06/20 03:32:32 pm
31.935USD
+0.05%
Prev.31.9200
Open31.9700
High32.1000
Low31.7900
Volume6 482 772
Financials
Sales 2018 9 839 M
EBIT 2018 2 507 M
R. net 2018 1 347 M
Debt 2018 4 828 M
Rend. 2018 -
P/E ratio 2018 33,03
P/E ratio 2019 27,05
EV / Sales 2018 5,02x
EV / Sales 2019 4,55x
Capitalization 44 554 M
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.The Cardiovascular segment comprises of technologies or...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2018-07-26 Earnings Release
Trading Rating :
Investor Rating :
Latest news
06/18How U.S. tax reform rewards companies that shift profit to tax havens
RE
06/18LATEST RESEARCH ON DIGESTIVE TRACT STENTS MARKET BY DEMANDING KEY PLAYERS LIKE BOSTON SCIENTIFIC, ASGE, WILLIS-KNIGHTON HEALTH SYSTEM, SEWOON MEDICAL CO., LTD., M. I. TEC : Digestive Tract Stents Market Report 2018
AQ
06/18BOSTON SCIENTIFIC : Cholangiocarcinoma Foundation Launches App to Track Medical History and Improve Care for Patients with Bile Duct Cancer
AQ
06/14BOSTON SCIENTIFIC : Patent Issued for Injectable Hydrogel Compositions (USPTO 9987221)
AQ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13S&P 500 MOVERS : Hrb, fox
AQ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance34,334,333,0
Spread/Res.-7,0%-7,0%-3,2%
Spread/Supp.7,8%7,8%12%
Support29,629,628,5